<unk>  is treated with intensive chemotherapy (such as anthracyclines) or with bone marrow transplantation. Tyrosine kinase receptor inhibitors are a prominent treatment developed to combat the over activation of cell proliferation proteins induced by AML-5. Inhibiting the STAT3 protein is another useful form of treatment.
Acute monocytic leukemia
Prolymphocytic leukemia
Acute myeloid leukemia
T-cell leukemia
Myeloid leukemia
Acute lymphoblastic leukemia
Monocytic leukemia
Acute promyelocytic leukemia